This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, Biosimilars & Animal Health. Check out our full report below:
Incyte Highlights P-III (TRuE-PN) Clinical Program Data of Opzelura (1.5% Ruxolitinib Cream) for Prurigo Nodularis (PN) at AAD 2025
Read More: Incyte
Johnson & Johnson Highlights P-III Clinical Data of Icotrokinra for Plaque Psoriasis at AAD 2025
Read More: J&J
Novo Nordisk Reveals P-III (REDEFINE 2) Trial data of CagriSema for Weight Loss in Obese/Overweight and T2D Patients
Read More: Novo Nordisk
Eli Lilly and Incyte Highlight P-III (BRAVE-AA-PEDS) Trial Data of Baricitinib for Alopecia Areata at AAD 2025
Read More: Eli Lilly and Incyte
Arvinas & Pfizer Reports Topline Data from P-III (VERITAC-2) Trial of Vepdegestrant for Breast Cancer
Read More: Arvinas & Pfizer
Merck Reports P-III (MK-8591A-052 & MK-8591A-051) Trial Data of Doravirine + Islatravir (DOR/ISL) for HIV-1 Infection in Adults
Read More: Merck
The EC Approves BMS’ Opdivo + Yervoy as 1L Treatment for Hepatocellular Carcinoma
Read More: BMS
AstraZeneca and Ionis’ Wainzua (Eplontersen) Receives the EC’s Approval to Treat Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Read More: AstraZeneca and Ionis
China’s NMPA Approves Kelun-Biotech's Sacituzumab Tirumotecan (sac-TMT) for EGFR-mutant NSCLC
Read More: Kelun-Biotech
Geron Receives the EC’s Approval for Rytelo (Imetelstat) to Treat Transfusion-Dependent Anemia due to Lower-Risk MDS
Read More: Geron
China’s NMPA Accepts BLA of Zai Lab’s Tivdak for Recurrent or Metastatic Cervical Cancer
Read More: Zai Lab
Otsuka and Lundbeck Receive the EC’s Approval for Rxulti to Treat Schizophrenia in Adolescents
Read More: Otsuka and Lundbeck
Nosis Biosciences Partners with Janssen Biotech for Cell-Targeted RNA Drugs
Read More: Nosis Biosciences and Janssen Biotech
Pierre Fabre Laboratories and RedRidge Bio Enter R&D Collaboration & License Agreement for Biparatopic Antibody (BPA) Candidates
Read More: Pierre Fabre Laboratories and RedRidge Bio
Ono Pharma and Ionis Enter into License Agreement for Sapablursen to Treat Polycythemia Vera
Read More: Ono Pharma and Ionis
Zealand Pharma and Roche enter a ~$5.3B Deal to Co-Develop and Commercialize Petrelintide for Weight Management
Read More: Zealand Pharma and Roche
The US FDA Grants 510(k) Clearance to Zimmer Biomet’s Persona Revision SoluTion Femur
Read More: Zimmer Biomet
Beckman Coulter Receives the US FDA 510(k) Clearance For DxC 500i Clinical Analyzer
Read More: Beckman Coulter
J&J MedTech Reports the US FDA‘s 510(k) Clearance of MONARCH QUEST for Robot-Assisted Bronchoscopy
Read More: J&J MedTech
Sun Pharma to Acquire Checkpoint Therapeutics For ~$355M
Read More: Sun Pharma & Checkpoint Therapeutics
Celltrion’s Omlyclo (Biosimilar, Xolair) Secures the US FDA’s Approval
Read More: Celltrion
Celltrion launches SteQeyma (Biosimilar, Stelara) in the US
Read More: Celltrion
Antech Launches trūRapid FOUR For Canine Vector-Borne Disease Screening
Read More: Antech
Kemin Industries Launches Prosidium to Improve Biosecurity in Animal Feed Industry & Supply
Read More: Kemin Industries
Related Post: PharmaShots Weekly Snapshots (March 03, 2025 – March 07, 2025)
